Cargando…

Sleep and Attention in Alzheimer’s Disease

Individuals with Alzheimer’s disease (AD) present with a wide variety of symptoms, including sleep disruption and sleep disorders. Conversely, disordered sleep has been associated with an increased risk of developing AD. Both conditions individually have adverse effects on attention, which can be fu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hennawy, Mirna, Sabovich, Solomon, Liu, Celina S., Herrmann, Nathan, Lanctôt, Krista L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	YJBM 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6430169/ https://www.ncbi.nlm.nih.gov/pubmed/30923473

Ejemplares similares

Exploring Visual Selective Attention towards Novel Stimuli in Alzheimer's Disease Patients
por: Chau, Sarah A., et al.
Publicado: (2015)

A Pilot Study Comparing Effects of Bifrontal Versus Bitemporal Transcranial Direct Current Stimulation in Mild Cognitive Impairment and Mild Alzheimer Disease
por: Liu, Celina S., et al.
Publicado: (2020)

Responsiveness of the QUALID to Improved Neuropsychiatric Symptoms in Patients with Alzheimer’s Disease
por: Benhabib, Hadas, et al.
Publicado: (2013)

Effect of Methylphenidate for Apathy on Visual Attention Scanning Behavior: a Pilot Study
por: Chau, Sarah A., et al.
Publicado: (2018)

Cardiovascular Risk Factors and Risk of Alzheimer Disease and Mortality: A Latent Class Approach
por: Ruthirakuhan, Myuri, et al.
Publicado: (2022)

Pharmacological recommendations for the symptomatic treatment of dementia: the Canadian Consensus Conference on the Diagnosis and Treatment of Dementia 2012
por: Herrmann, Nathan, et al.
Publicado: (2013)

The Effect of Exercise Training on Resting Concentrations of Peripheral Brain-Derived Neurotrophic Factor (BDNF): A Meta-Analysis
por: Dinoff, Adam, et al.
Publicado: (2016)

State, trait, and accumulated features of the Alzheimer's Disease Assessment Scale Cognitive Subscale (ADAS‐Cog) in mild Alzheimer's disease
por: Cogo‐Moreira, Hugo, et al.
Publicado: (2023)

Cognitive Outcomes following Transcatheter Aortic Valve Implantation: A Systematic Review
por: Lai, Ka Sing Paris, et al.
Publicado: (2015)

The Relationship between Oxidative Stress and Subjective Sleep Quality in People with Coronary Artery Disease
por: Feng, Vivian, et al.
Publicado: (2022)

White matter hyperintensities in autopsy-confirmed frontotemporal lobar degeneration and Alzheimer’s disease
por: Desmarais, Philippe, et al.
Publicado: (2021)

A meta-analysis of lipid peroxidation markers in major depression
por: Mazereeuw, Graham, et al.
Publicado: (2015)

24S-Hydroxycholesterol Is Associated with Agitation Severity in Patients with Moderate-to-Severe Alzheimer’s Disease: Analyses from a Clinical Trial with Nabilone
por: Ruthirakuhan, Myuri, et al.
Publicado: (2019)

Investigating the safety and efficacy of nabilone for the treatment of agitation in patients with moderate-to-severe Alzheimer's disease: Study protocol for a cross-over randomized controlled trial
por: Ruthirakuhan, Myuri T., et al.
Publicado: (2019)

Serum low-density lipoprotein levels, statin use, and cognition in patients with coronary artery disease
por: Rej, Soham, et al.
Publicado: (2016)

Questioning the Meaning of a Change on the Alzheimer’s Disease Assessment Scale–Cognitive Subscale (ADAS-Cog): Noncomparable Scores and Item-Specific Effects Over Time
por: Cogo-Moreira, Hugo, et al.
Publicado: (2020)

Exercise priming with transcranial direct current stimulation: a study protocol for a randomized, parallel-design, sham-controlled trial in mild cognitive impairment and Alzheimer’s disease
por: Liu, Celina S., et al.
Publicado: (2021)

A peripheral neutrophil-related inflammatory factor predicts a decline in executive function in mild Alzheimer’s disease
por: Bawa, Kritleen K., et al.
Publicado: (2020)

Leukotriene receptor antagonist use and cognitive decline in normal cognition, mild cognitive impairment, and Alzheimer’s dementia
por: Xiong, Lisa Y., et al.
Publicado: (2021)

Neurobiologic Rationale for Treatment of Apathy in Alzheimer’s Disease With Methylphenidate
por: van Dyck, Christopher H., et al.
Publicado: (2020)

Lipid Peroxidation Markers in Coronary Artery Disease Patients with Possible Vascular Mild Cognitive Impairment
por: Suridjan, Ivonne, et al.
Publicado: (2017)

Sex differences in neuropsychiatric symptoms in Alzheimer’s disease dementia: a meta-analysis
por: Eikelboom, Willem S., et al.
Publicado: (2022)

Altered central and blood glutathione in Alzheimer’s disease and mild cognitive impairment: a meta-analysis
por: Chen, Jinghan Jenny, et al.
Publicado: (2022)

Platelet-activating factors are associated with cognitive deficits in depressed coronary artery disease patients: a hypothesis-generating study
por: Mazereeuw, Graham, et al.
Publicado: (2014)

Effects of methylphenidate on neuropsychiatric symptoms in Alzheimer's disease: Evidence from the ADMET 2 study
por: Clark, Emily D., et al.
Publicado: (2023)

Medical Cannabis Use Among Older Adults in Canada: Self-Reported Data on Types and Amount Used, and Perceived Effects
por: Tumati, Shankar, et al.
Publicado: (2021)

The “DOC” screen: Feasible and valid screening for depression, Obstructive Sleep Apnea (OSA) and cognitive impairment in stroke prevention clinics
por: Swartz, Richard H., et al.
Publicado: (2017)

Impact of 12-week exercise program on biomarkers of gut barrier integrity in patients with coronary artery disease
por: Feng, Vivian, et al.
Publicado: (2021)

Burden of Illness in People with Alzheimer’s Disease: A Systematic Review of Epidemiology, Comorbidities and Mortality
por: Lanctôt, Krista L., et al.
Publicado: (2023)

Relationship between hair cortisol concentrations and depressive symptoms in patients with coronary artery disease
por: Dowlati, Yekta, et al.
Publicado: (2010)

Baseline Oxidative Stress Is Associated with Memory Changes in Omega-3 Fatty Acid Treated Coronary Artery Disease Patients
por: Mazereeuw, Graham, et al.
Publicado: (2017)

The use of angiotensin-converting enzyme inhibitors vs. angiotensin receptor blockers and cognitive decline in Alzheimer’s disease: the importance of blood-brain barrier penetration and APOE ε4 carrier status
por: Ouk, Michael, et al.
Publicado: (2021)

Is Cardiac Rehabilitation Exercise Feasible for People with Mild Cognitive Impairment?
por: Intzandt, Brittany, et al.
Publicado: (2015)

Treatment effects in multiple cognitive domains in Alzheimer’s disease: a two-year cohort study
por: Behl, Pearl, et al.
Publicado: (2014)

Omega-3 Fatty Acids, Depressive Symptoms, and Cognitive Performance in Patients With Coronary Artery Disease: Analyses From a Randomized, Double-Blind, Placebo-Controlled Trial
por: Mazereeuw, Graham, et al.
Publicado: (2016)

Subcortical hyperintensities in the cholinergic system are associated with improvements in executive function in older adults with coronary artery disease undergoing cardiac rehabilitation
por: Santiago, Calvin, et al.
Publicado: (2017)

Ceramide Accumulation Is Associated with Declining Verbal Memory in Coronary Artery Disease Patients: An Observational Study
por: Chan, Parco, et al.
Publicado: (2018)

Platelet activating factors are associated with depressive symptoms in coronary artery disease patients: a hypothesis-generating study
por: Mazereeuw, Graham, et al.
Publicado: (2015)

Centre- versus home-based exercise among people with mci and mild dementia: study protocol for a randomized parallel-group trial
por: Middleton, Laura E., et al.
Publicado: (2018)

Plasma sphingolipids and depressive symptoms in coronary artery disease
por: Dinoff, Adam, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_nmfj2q74k0miirfnjm8o4njjre